Precision, Not Just Protocols: India’s Cancer Care Shifts Toward Global Collaboration and Personalized Pathways

NEW DELHI – Leading oncologists and public health experts gathered in the national capital this week for the launch of the Fortis Cancer Summit 2026, signaling a transformative shift in the nation’s approach to oncology. The consensus among the international delegation is clear: the future of cancer survival in India depends on moving away from rigid, “one-size-fits-all” protocols in favor of global data sharing and highly personalized treatment pathways tailored to the genetic blueprint of individual patients.

The two-day summit, hosted by Fortis Healthcare, has convened specialists from India and over 25 countries. The core message—“Beyond Evidence-Based Oncology”—advocates for an evolution into “evidence-informed, patient-centered care” to bridge the gap between clinical trial results and real-world survival outcomes.

From Global Insights to Individualized Care

The summit marks a departure from treating cancer solely by textbook guidelines. Instead, organizers are pushing for the integration of genomic data, advanced diagnostics, and multidisciplinary tumor boards into everyday clinical practice.

International delegates, including Dr. Iliya Karniliyus Salu, Chief Medical Director at Trust Charitos Hospital in Abuja, Nigeria, emphasized that modern oncology challenges—such as drug resistance and disparities in access—are global phenomena.

“Lessons from low- and middle-income settings, where resources are often limited, can help refine cost-effective, high-impact strategies in wealthier nations and vice versa,” Dr. Salu noted during a pre-summit press conference.

Dr. Nitesh Rohatgi and Dr. Ankur Bahl, leaders in Medical Oncology at Fortis, added that the summit’s primary goal is to translate cutting-edge research into “real-world clinical workflows.” The objective is to ensure that advances in precision medicine and biomarker-driven therapies reach routine care settings rather than remaining confined to elite research institutions.

The Science of Personalization: Precision Oncology

Personalized, or “precision,” oncology relies on identifying a tumor’s unique molecular profile. By matching specific genetic mutations with targeted drugs, doctors can attack a cancer’s vulnerabilities while sparing patients the unnecessary toxicity of traditional chemotherapy.

This approach has already yielded significant success in treating non-small-cell lung cancer (NSCLC) and melanoma. In India, major cancer centers in cities like Gurugram, Mumbai, and Bengaluru are increasingly utilizing next-generation sequencing (NGS) to guide treatment. However, experts at the summit warned that access remains uneven across the subcontinent. Standardizing these best practices through international collaboration is seen as a vital step in ensuring geographic location does not determine a patient’s quality of care.

Bridging the Gap with AI and Real-World Data

A significant portion of the summit focused on the role of Artificial Intelligence (AI) and real-world data (RWD) in refining treatment. Unlike tightly controlled clinical trials, RWD—drawn from electronic health records—provides insights into how diverse populations respond to drugs in everyday life.

Dr. Ankur Bahl highlighted how AI-driven analytics can help oncologists anticipate which patients might experience severe side effects, allowing for earlier intervention.

“These tools allow us to adjust dosages and interventions before a crisis occurs, potentially reducing hospitalizations,” Dr. Bahl explained.

However, speakers maintained a note of caution: AI should supplement, not replace, clinical judgment. Transparency in algorithmic decision-making remains a priority to ensure human oversight in complex cases.

The Crisis of Head and Neck Cancers in India

Amidst the discussion of high-tech cures, a sobering public health message emerged regarding the burden of head and neck cancers in India. Driven largely by tobacco use—including smoking and smokeless forms like gutka and pan masala—India records over 200,000 new cases of oral and throat cancers annually.

Data presented at the summit revealed a distressing trend: a substantial proportion of these patients are young adults under the age of 50. Hospital-based studies from eastern India reported that over 95% of oral cancer patients had a history of tobacco exposure.

Experts urged for a “prevention-first” model, combining:

• Community-based oral screening programs.

• Stringent tobacco-control policies.

• Affordable biopsy and imaging services in rural districts.

Addressing the Rural-Urban Divide

Despite the technological optimism of the summit, the “rural-urban divide” remains a formidable barrier. Public health advocates referenced data showing that patients in remote districts often travel hundreds of kilometers to reach radiotherapy centers, leading to significant treatment delays.

To combat this, the summit proposed a multi-pronged approach:

1. Tele-oncology: Remote consultations for follow-ups and initial screenings.

2. Mobile Screening Vans: Bringing diagnostics to underserved villages.

3. Infrastructure Investment: Strengthening primary care training so local doctors can recognize early warning signs.

Limitations and Practical Considerations

While the narrative of personalized care is compelling, oncologists outside the summit’s main program cautioned that it is not a “silver bullet.” Precision oncology currently benefits only a subset of patients whose tumors harbor specific, treatable mutations. Furthermore, the high cost of genetic testing and targeted biological therapies remains a barrier for many Indian families.

Genetic testing can also yield “ambiguous variants”—results that are neither clearly harmful nor clearly benign—which can lead to patient anxiety and complex clinical decision-making. Experts recommend that all genetic testing be paired with robust counseling and multidisciplinary review.

What This Means for Patients and Families

As India pivots toward this new model of care, health-conscious consumers and patients should consider the following:

• Early Detection is Key: Persistent mouth ulcers, hoarseness, or unexplained weight loss should be evaluated immediately by a specialist, especially for those with a history of tobacco use.

• Seek Multidisciplinary Teams: Optimal outcomes are often achieved in centers where medical, surgical, and radiation oncologists collaborate on a single treatment plan.

• Ask About Genomic Profiling: Patients should feel empowered to ask their doctors if molecular testing or clinical trials are appropriate for their specific diagnosis.

• Shared Decision-Making: Treatment should reflect the patient’s goals regarding quality of life and financial considerations, moving beyond just “what the textbook says.”

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• Hindustan Times. “Cancer care bolstered with diverse clinical experiences, personalised approach: Experts.” May 1, 2026.